Skip to main content
Smart Investors Daily
CL

OTC · CLVLY

Clinuvel Pharmaceuticals Limited

Healthcare · Biotechnology

$6.74

Up+$0.07 (+0.97%)

Updated Aug 28, 2026, 2:44 AM

SID Score

4.9/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
417.17M
P/E ratio
16.98
Dividend yield
0.48%
52-week range
— – —
Volume
152
Avg. volume
2.9K

Price performance

CLVLY price history

1M range · 0 trading sessions · Daily adjusted prices

CLVLY does not have enough price history for the selected period.

Data unavailable

Market data is busy. Please try again shortly.

Latest CLVLY news

The latest Smart Investors Daily articles mentioning CLVLY.

CLVLY research

Overview

Company profile and research snapshot.

Company profile

CLINUVEL PHARMS LTD S/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Average target
Implied upside
Analysts
CLVLY recent ratings
DateFirmRatingTarget
Jul 13, 2026BELL POTTER SECURITIESBuy
Jun 4, 2026JEFFERIESBuy
Jun 3, 2026BELL POTTER SECURITIESBuy
May 26, 2026PARMANTIER & CIEBuy
Apr 1, 2026BELL POTTER SECURITIESBuy
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Feb 3, 2026

Exploring 3 High Growth Tech Stocks in Australia

The Australian stock market is experiencing a potential rebound, with shares expected to rise by over 1% following recent sell-offs, as investors anticipate the Reserve Bank of Australia's impending interest rate hike decision. In this dynamic environment, high-growth tech stocks can offer intriguing opportunities for investors seeking innovation and resilience amidst economic shifts and evolving global strategies.

Yahoo · Jan 29, 2026

ASX Growth Companies With High Insider Ownership January 2026

As the Australian market navigates a period of uncertainty with flat trading and cautious investor sentiment following the U.S. Federal Reserve's recent decision to hold interest rates steady, attention turns to how local indices will respond to upcoming announcements from the Reserve Bank of Australia. In this environment, growth companies with high insider ownership can be particularly appealing, as they often signal strong confidence from those who know the business best and may offer...

Yahoo · Jan 28, 2026

High Growth Tech Stocks To Watch In January 2026

As Australian shares continue their upward trajectory, buoyed by a rally in the S&P 500 and anticipation surrounding upcoming inflation data, investors are closely watching how these factors might influence future Reserve Bank of Australia rate decisions. In this dynamic environment, high growth tech stocks can be particularly appealing for their potential to capitalize on market optimism and technological advancements, making them worthy of attention as we enter January 2026.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.